New York Life Investment Management’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,190
| Closed | -$410K | – | 1128 |
|
|
2024
Q1 | $410K | Buy |
9,190
+1,817
| +25% | +$81K | ﹤0.01% | 804 |
|
|
2023
Q4 | $286K | Sell |
7,373
-170
| -2% | -$6.6K | ﹤0.01% | 1237 |
|
|
2023
Q3 | $222K | Sell |
7,543
-1,189
| -14% | -$35K | ﹤0.01% | 1261 |
|
|
2023
Q2 | $555K | Sell |
8,732
-1,362
| -13% | -$86.6K | 0.01% | 664 |
|
|
2023
Q1 | $476K | Buy |
+10,094
| New | +$476K | 0.01% | 981 |
|